This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 29846124 Submitted by lobbyist on: December 22, 2016 10:57:14 AM Accepted by Registrar on: December 22, 2016 02:13:28 PM
Designated Filer Information
Landau, Craig
575 Granite Court
Pickering, ON, L1W 3W8
905-420-6400
Canada
Organization Information
Purdue Pharma
Purdue Pharma is a research-based pharmaceutical company in Pickering, Ontario, Purdue Pharma (Canada) is committed to improving patient health and well-being by developing innovative medicines and supporting quality education for the safe use of its products. Purdue is a recognized leader in research and development of products for the treatment of pain. Its portfolio of products also includes medication for the treatment of attention deficit hyperactivity disorder (ADHD), respiratory disease, gastrointestinal disorders and infection control.
575 Granite Court
Pickering, BC, L1W 3W8
604-366-8006
Canada
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Active Registration Period
December 22, 2016
June 20, 2017
Organization's In-House Lobbyists
Name:
Gaskin, Howard
December 22, 2016
Inactivation Date:
June 27, 2017
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Responsible prescribing of medication, value of Abuse Deterrent Formulations as a means of ensuring appropriate and responsible access to and use of prescription medicines, preparation for the introduction of new generations of existing medications.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Staff of Minister
Minister of Health
December 22, 2016
Staff of Minister
Minister of Health
December 22, 2016
Public Agency
Health
December 22, 2016
Name:
Landau, Craig
December 22, 2016
Inactivation Date:
June 27, 2017
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Responsible prescribing of medication, value of Abuse Deterrent Formulations as a means of ensuring appropriate and responsible access to and use of prescription medicines, preparation for the introduction of new generations of existing medications.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Staff of Minister
Minister of Health
December 22, 2016
Staff of Minister
Minister of Health
December 22, 2016
Public Agency
Health
December 22, 2016
Name:
Perry, Grant
December 22, 2016
Inactivation Date:
June 27, 2017
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Responsible prescribing of medication, value of Abuse Deterrent Formulations as a means of ensuring appropriate and responsible access to and use of prescription medicines, preparation for the introduction of new generations of existing medications.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Staff of Minister
Minister of Health
December 22, 2016
Staff of Minister
Minister of Health
December 22, 2016
Public Agency
Health
December 22, 2016
Name:
Spigelman, Aleina
December 22, 2016
Inactivation Date:
June 27, 2017
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Responsible prescribing of medication, value of Abuse Deterrent Formulations as a means of ensuring appropriate and responsible access to and use of prescription medicines, preparation for the introduction of new generations of existing medications.
